49 in two months. Enjoy!
Tomassoni AJ, Hawk KF,
Jubanyik K, Nogee DP, Durant T, Lynch KL, Patel R, Dinh D, Ulrich A, D'Onofrio
G.
MMWR Morb Mortal Wkly Rep.
2017 Feb 3;66(4):107-111. doi: 10.15585/mm6604a4.
Comments: Nice
description of an outbreak of and public health response to insufflated
fentanyl causing severe overdose.
Kobayashi L, Green TC,
Bowman SE, Ray MC, McKenzie MS, Rich JD.
Simul Healthc. 2017
Feb;12(1):22-27. doi: 10.1097/SIH.0000000000000182.
Comments: Interesting
and rigorous way to evaluate overdose knowledge after naloxone provision.
Tylleskar I, Skulberg AK, Nilsen
T, Skarra S, Jansook P, Dale O.
Eur J Clin Pharmacol. 2017
Jan 31. doi: 10.1007/s00228-016-2191-1. [Epub ahead of print]
Comments: Data
from another nasal naloxone in development.
Eggleston W, Clemency BM.
Clin Toxicol (Phila). 2017
Jan 31:1-3. doi: 10.1080/15563650.2017.1284336. [Epub ahead of print] No
abstract available.
Comments: Authors
note that data on the safety of discharging patients after an hour of
observation may not apply in the current era of synthetic opioids.
Freeman PR, Goodin A,
Troske S, Strahl A, Fallin A, Green TC.
J Am Pharm Assoc (2003).
2017 Jan 28. pii: S1544-3191(16)31004-4. doi: 10.1016/j.japh.2016.12.064. [Epub
ahead of print]
Comments: Mixed
opinions.
Lancaster K, Treloar C,
Ritter A.
Health (London). 2017 Jan
1:1363459316688520. doi: 10.1177/1363459316688520. [Epub ahead of print]
Comments: Interesting
article on whose knowledge matters.